본문 바로가기
bar_progress

Text Size

Close

Choi Tae-won Inspects Semiconductor Materials and Bio US Operations as 'Future Growth Engines'

SK Biopharm Visits Absolix, a Subsidiary of SKC

Choi Tae-won, chairman of SK Group, visited sites of future growth engines such as semiconductor materials and bio industries during his business trip to the United States.


Choi Tae-won Inspects Semiconductor Materials and Bio US Operations as 'Future Growth Engines' SK Group Chairman Chey Tae-won visited the headquarters of SK Life Science, the U.S. subsidiary of SK Biopharm, in New Jersey, USA, on the 2nd (local time) to check the status of the bio business.
[Photo by SK Supex Council]

According to SK Group on the 7th, Chairman Choi met consecutively with CEOs of OpenAI, Microsoft, Amazon, and Intel starting from the 22nd of last month, then moved east to visit local subsidiaries. On the 2nd (local time), he visited the headquarters of SK Life Science, the U.S. subsidiary of SK Biopharm, located in New Jersey. There, he checked on the direct sales status in the U.S. of 'Cenobamate' (U.S. product name 'Xcopri'), SK Biopharm's innovative new drug for epilepsy.


Cenobamate recently surpassed 100,000 total prescriptions, proving its efficacy and safety in the epilepsy field and emerging as a rising star in the new drug market. Chairman Choi urged, "Please carefully review the potential impact of the recent U.S. Biosecurity Act on national security policy and prepare countermeasures." The Biosecurity Act primarily restricts Chinese bio companies from operating in the U.S.


The next day, Chairman Choi visited Absolix in Covington, Georgia, toured the world's first glass substrate patterning factory, and received a business status report. Absolix is a subsidiary established by SKC in 2021 for the high-performance computing semiconductor glass substrate business.


Glass substrates are attracting attention as a 'game changer' that can dramatically improve data speed and power consumption in semiconductor packages. The world's first commercialization of glass-based substrates is scheduled for customer testing in the second half of the year. In particular, demand for high-purity glass substrates is expected to increase with the rapid growth of the artificial intelligence (AI) semiconductor market, including high-bandwidth memory (HBM).


© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Special Coverage


Join us on social!

Top